These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15621122

  • 21. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [Abstract] [Full Text] [Related]

  • 22. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J, Li S, Levi M, Weinberg A.
    J Clin Virol; 2011 Nov; 52(3):231-5. PubMed ID: 21900040
    [Abstract] [Full Text] [Related]

  • 23. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
    Moran J, Carr M, Waters A, Boyle S, Riordan M, Connell J, Awan A, Hall W, Hassan J.
    Transplantation; 2011 Aug 15; 92(3):328-33. PubMed ID: 21685826
    [Abstract] [Full Text] [Related]

  • 24. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.
    J Med Virol; 2008 Mar 15; 80(3):441-54. PubMed ID: 18205222
    [Abstract] [Full Text] [Related]

  • 25. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
    Jabs WJ, Hennig H, Kittel M, Pethig K, Smets F, Bucsky P, Kirchner H, Wagner HJ.
    J Clin Microbiol; 2001 Feb 15; 39(2):564-9. PubMed ID: 11158107
    [Abstract] [Full Text] [Related]

  • 26. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 15; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 27. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
    Zawilinska B, Kosinska A, Lenart M, Kopec J, Piatkowska-Jakubas B, Skotnicki A, Kosz-Vnenchak M.
    Acta Biochim Pol; 2008 May 15; 55(4):693-9. PubMed ID: 19015775
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec 15; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 32. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
    Bergallo M, Costa C, Baro S, Musso T, Balbo L, Merlino C, Cavallo R.
    J Biotechnol; 2007 Feb 20; 128(3):462-76. PubMed ID: 17147963
    [Abstract] [Full Text] [Related]

  • 33. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
    Hézode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens AL, Gaulard P, Cherqui D, Pawlotsky JM, Dhumeaux D.
    Hepatology; 1999 Sep 20; 30(3):775-8. PubMed ID: 10462385
    [Abstract] [Full Text] [Related]

  • 34. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 20; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 35. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Feb 20; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 36. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K.
    Scand J Infect Dis; 2007 Feb 20; 39(3):235-44. PubMed ID: 17366054
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug 20; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A, Spieker T, Mottok A, Baur AS, Küppers R, Hansmann ML.
    Eur J Immunol; 2003 Jun 20; 33(6):1593-602. PubMed ID: 12778477
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.